Amplify Weight Loss Drug & Treatment ETF (THNR)
NYSEARCA: THNR · Real-Time Price · USD
27.58
+0.33 (1.21%)
Aug 21, 2026, 1:39 PM EDT - Market open
THNR Holdings Information
THNR is an equity ETF with a total of 22 individual holdings. The top holdings are Novo Nordisk stock at 9.25%, Eli Lilly and Company at 9.08%, Regeneron Pharmaceuticals at 6.13%, Innovent Biologics at 5.85%, and CSPC Pharmaceutical Group at 5.54%.
Total Holdings
22
Top 10 Percentage
62.04%
Asset Class
Equity
ETF Category
Health
Assets
5.29M
PE Ratio
18.42
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | NVO | Novo Nordisk A/S | 9.25% |
| 2 | LLY | Eli Lilly and Company | 9.08% |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 6.13% |
| 4 | HKG: 1801 | Innovent Biologics, Inc. | 5.85% |
| 5 | HKG: 1093 | CSPC Pharmaceutical Group Limited | 5.54% |
| 6 | AMGN | Amgen Inc. | 5.48% |
| 7 | SRRK | Scholar Rock Holding Corporation | 5.36% |
| 8 | ARWR | Arrowhead Pharmaceuticals, Inc. | 5.19% |
| 9 | SWX: ROP | Roche Holding AG | 5.11% |
| 10 | MRK | Merck & Co., Inc. | 5.07% |
| 11 | ABBV | AbbVie Inc. | 5.04% |
| 12 | PFE | Pfizer Inc. | 4.75% |
| 13 | VKTX | Viking Therapeutics, Inc. | 4.51% |
| 14 | HIMS | Hims & Hers Health, Inc. | 4.50% |
| 15 | TYO: 4519 | Chugai Pharmaceutical Co., Ltd. | 4.35% |
| 16 | CPH: ZEAL | Zealand Pharma A/S | 4.03% |
| 17 | LON: AZN | AstraZeneca PLC | 4.01% |
| 18 | KRX: 128940 | Hanmi Pharm. Co., Ltd. | 2.13% |
| 19 | JNGHF | Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 2.09% |
| 20 | KLRA | Kailera Therapeutics, Inc. | 1.95% |
| 21 | AGPXX | Invesco Short-Term Investments Trust Government & Agency Portfolio Institutional Class | 0.37% |
| 22 | n/a | OTHER ASSETS AND LIABILITIES | 0.24% |
As of Aug 13, 2026